These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2722371)

  • 1. Prevalence of antibodies to human immunodeficiency virus among intravenous drug users in Israel--association with travel abroad.
    Dan M; Rock M; Bar-Shany S
    Int J Epidemiol; 1989 Mar; 18(1):239-41. PubMed ID: 2722371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection among intravenous drug addicts in Israel--stable low prevalence over 34 months.
    Dan M; Cahana A; Fintsi Y; Bar-Shany S
    Int J Epidemiol; 1992 Jun; 21(3):561-3. PubMed ID: 1634320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.
    Des Jarlais DC; Friedman SR; Novick DM; Sotheran JL; Thomas P; Yancovitz SR; Mildvan D; Weber J; Kreek MJ; Maslansky R
    JAMA; 1989 Feb; 261(7):1008-12. PubMed ID: 2915408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
    Nicolosi A; Leite ML; Musicco M; Molinari S; Lazzarin A
    Am J Epidemiol; 1992 Feb; 135(3):225-33. PubMed ID: 1312300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and intravenous drug abuse: world perspective and epidemiology in Israel.
    Dan M
    Isr J Med Sci; 1993 Oct; 29(10 Suppl):11-4. PubMed ID: 8244674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence area.
    Chandrasekar PH; Molinari JA; Kruse JA
    South Med J; 1990 Sep; 83(9):996-1001. PubMed ID: 2402666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV among Israeli intravenous drug abusers.
    Maayan S; Dan M; Marlink R; Chen YM
    Int J Epidemiol; 1992 Oct; 21(5):995-7. PubMed ID: 1468865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
    Seligman PJ; Campbell RJ; Keeler GP; Halpin TJ
    Ohio Med; 1989 Jan; 85(1):56-9. PubMed ID: 2927870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV-1 infection among injection drug users in Montreal, 1985-1987.
    Lamothe F; Bruneau J; Soto J; Brabant M; Vincelette J
    Can Dis Wkly Rep; 1988 Dec; 14(50):225-7. PubMed ID: 3242908
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986.
    Mascola L; Lieb L; Iwakoshi KA; McAllister D; Siminowski T; Giles M; Run G; Fannin SL; Strantz IH
    Am J Public Health; 1989 Jan; 79(1):81-2. PubMed ID: 2909190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).
    D'Aquila RT; Williams AB
    Yale J Biol Med; 1987; 60(6):545-67. PubMed ID: 3324506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV infection among intravenous drug users in the United States.
    Hahn RA; Onorato IM; Jones TS; Dougherty J
    JAMA; 1989 May; 261(18):2677-84. PubMed ID: 2651732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenic purpura in HIV-seronegative users of intravenous cocaine.
    Koury MJ
    Am J Hematol; 1990 Oct; 35(2):134-5. PubMed ID: 2399906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users.
    Selwyn PA; Schoenbaum EE; Davenny K; Robertson VJ; Feingold AR; Shulman JF; Mayers MM; Klein RS; Friedland GH; Rogers MF
    JAMA; 1989 Mar; 261(9):1289-94. PubMed ID: 2915455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
    Brenner B; Schwartz S; Ben-Porath E; Tatarsky I; Varon D; Martinowitz U
    Isr J Med Sci; 1991 Oct; 27(10):557-61. PubMed ID: 1955309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.
    Selwyn PA; Feingold AR; Hartel D; Schoenbaum EE; Alderman MH; Klein RS; Friedland GH
    AIDS; 1988 Aug; 2(4):267-72. PubMed ID: 3140832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.